In particular, along with the redistribution of CLL cells from the spleen and lymph nodes into the circulation, IBR inhibits their activation and proliferation [38,39] and impairs CXCR4 signalling [40]. The gene discussed is CXCR4; the disease is B-cell chronic lymphocytic leukemia.